Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Renee Nicole Good also won one of Old Dominion's most prestigious accolades, the American Academy of American Poets Prize.

I’M CAROL CLARKE A GREENVILLE MAN SAYS EVERYTHING THAT HAPPENED AFTER JUNE OF LAST YEAR IS BONUS TIME. A SPECIAL GIFT. ALL BECAUSE HE SURVIVED A DISSECTED AORTA. GIFTED DOCTORS AT PRISMA HEALTH AND A ...

The cover of "Twice Born" and author Hester Kaplan. (Courtesy of Catapult and Rupert Whiteley) Hester Kaplan felt as though she never knew her father, Pulitzer Prize and National Book Award-winning ...

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

The MarketWatch News Department was not involved in the creation of this content. PALO ALTO, Calif. and NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bitterroot Bio, a leader in developing ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Shanghai Bio-Heart ...